Earn points on every order · Free shipping on orders over $159 · New products in stock
← Back to Compound Library
Reproductive and Hormonal

PT-141 (Bremelanotide)

Vyleesi. FDA-approved for low sex drive in women. Works on arousal in the brain, not blood flow. Take it 30–90 minutes before sex.

Research referenceCommunity compiled
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Vyleesi.

FDA-approved for low sex drive in women.

Works on arousal in the brain, not blood flow.

Take it 30–90 minutes before sex.

What It Does

FDA-approved melanocortin agonist for HSDD, activates MC4R in the brain to increase sexual desire and arousal centrally.

Activates MC4R in hypothalamic arousal circuits.

Unlike PDE5 inhibitors (blood flow), PT-141 works on the brain; see the comparison on the next page.

Reconstitution

Vial SizeBAC Water / SolventConcentration
10 mg+ 1 mL10 mg/mL
Interactive tool

Reconstitution Calculator

Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.

Calculated concentration—Enter both values above.
Optional conversion

Enter a target amount you already have and select the syringe capacity.

Calculated draw—Enter concentration inputs and a target amount.

Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.

Protocol

PhaseFrequencyAmountNotes
FDA doseAs-needed1.75FDA-approved Vyleesi dose.
CommunityAs-needed1–2Off-label research.
Max1×/day,–FDA Vyleesi label: max 1 dose per 24 hours AND max 8 doses per month. Exceeding 8/month carries significantly
Cycle & Timing

As-needed (situational) per FDA Vyleesi label. Max 1 dose per 24 hours; max 8 doses per month. Not for daily or scheduled use.

Timing

Single shot 30–90 min before sexual activity (situational).

Population Considerations

FDA-approved (Vyleesi) for premenopausal women with low sexual desire (HSDD). Nausea common. Men: Began as a men’s erectile-dysfunction drug (acts in the brain, adds to sildenaf FDA-approved (Vyleesi) for premenopausal women with low sexual desire (HSDD). Nausea common. Men: Began as a men’s erectile-dysfunction drug (acts in the brain, adds to sildenafil).

Handling & Stacking

Injection site
Abdomen SubQ.
Storage
  • Freeze-dried: -4°F.
  • Reconstituted: 36–46°F.
  • Best used within 28 days.
  • No clear reconstituted-potency data (the label lists only an in-use date, not potency), so defer to the 28-day sterility limit.
Side effects
  • Nausea, flushing, BP elevation (transient).
  • Less nausea PM vs AM.
  • Focal hyperpigmentation (face/gums/breasts): ~1% with intermittent as-needed use, but 38% when dosed daily for 8 consecutive days (FDA Vyleesi label); argues strongly against scheduled daily dosing.
What to expect
  • Sexual desire and arousal within 30–60 min.
  • Duration 6–24 hours.
  • Nausea and flushing common, less if dosed in the evening.
  • Use caution if combining with PDE5 inhibitors (sildenafil, tadalafil); additive transient BP and HR effects; not an FDA-labeled contraindication.
Pairs well with
Melanotan II (MT-2) (libido + tan); Kisspeptin-10 (HPG axis support)
Avoid
  • Uncontrolled hypertension (transient BP rise on injection).
  • PDE5 inhibitors at peak (additive transient BP elevation).
  • Cardiovascular disease Next page: how PT-141 compares to Viagra and Cialis (desire vs blood flow, which fixes which problem), plus the full safety block.
  • PT-141 vs VIAGRA & CIALIS, AND SAFETY
The difference
  • They fix different problems, which is why one can work when the other doesn’t.
  • Viagra and Cialis are plumbing, they open blood flow so an erection can happen, but only if you’re already turned on.
  • PT-141 is the brain, it creates the wanting.
  • Quick test: “want to but can’t” → Viagra/Cialis. “Can but don’t want to” → PT-141.
PT-141
Viagra (sildenafil) Cialis (tadalafil)

What It Does

Brain, switches on desire/arousal Blood flow, keeps an erection holding Works without arousal? Yes, it creates the arousal No, you must already be aroused Best for Low desire; or pills work but you feel nothing Erection trouble, on demand Erection trouble; also BPH How to take SubQ, 45 min–2 h before; max 1/24 h, 8/month Pill ~1 h before; 25/50/100 mg Pill 10/20 mg PRN, or 2.5–5 mg daily Lasts ~6–24 h ~4–6 h Up to 36 h FDA-approved Women (HSDD), as Vyleesi; men off-label Yes; erectile dysfunction in men Hard no Melanoma / atypical moles; uncontrolled BP; Never with nitrates (nitroglycerin, “poppers”); dangerous BP crash. Cialis: none within 48 h heart disease Together? Different systems, so combining is plausible and under study; but both affect blood pressure, so stacking at peak can cause dizziness. Clinician conversation, not a DIY stack. Honest read: the pills are the proven, approved, cheap option for men; PT-141 is the one that treats desire, which they can’t; but for men it’s off-label, injected, and nausea is common.

Safety & Patient Education

Contraindications
Personal or family history of melanoma Atypical mole syndrome / dysplastic nevus syndrome Active skin cancer or pre-malignant skin lesions Uncontrolled hypertension; significant cardiovascular disease Pregnancy and lactation
Warnings
  • Hyperpigmentation of all melanocytes including existing moles (mole monitoring required); new mole formation.
  • Transient BP elevation (~6 mmHg systolic per Vyleesi label).
  • Nausea (most pronounced AM, less PM).
  • Reduced response / tachyphylaxis with frequent use.
Drug interactions
  • PDE5 inhibitors (sildenafil, tadalafil, vardenafil): additive BP; separate timing per label.
  • Antihypertensives / vasoactive drugs: additive or paradoxical BP effects.
  • Naltrexone: decreases naltrexone exposure significantly.
  • Narrow-TI oral meds: delayed absorption.
Labs
  • Blood pressure before each dose (bremelanotide transiently raises BP and lowers heart rate 2–4 h post-dose – skip it if you’ve got uncontrolled hypertension or known cardiovascular disease).
  • Dermatology baseline mole mapping (photographic), repeat every 12 weeks during active use and every 6–12 months after (melanocortin agonist can darken skin and moles)., Out of range?
  • A BP spike after dosing or a new/changing mole = stop and get checked; don’t use it with heart disease or high blood pressure that isn’t controlled.
Stop criteria
New atypical mole or rapid change (ABCDE); sustained BP >140/90 in a previously normotensive patient; priapism (>4 h erection), emergency care; severe nausea not resolving with dose reduction; persistent hyperpigmentation.
Patient education
  • Photograph moles at baseline; recheck monthly (ABCDE: Asymmetry, Border, Color, Diameter >6mm, Evolution).
  • Use sunscreen, extra melanin doesn’t replace UV protection.
  • Do not exceed 1 dose/24 h or 8 doses/month (Vyleesi label).
  • Erection >4 h is a medical emergency.
  • Tell any prescriber before combining with an ED pill.
References
researchdosing · peptidedosages · DailyMed · Kingsberg 2019 · Wessells 2000